Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of perioperative chemotherapy in resected colorectal liver metastasis: A systematic review and meta-analysis
Authors
Keywords
Colorectal neoplasms, Liver metastases, Chemotherapy, Survival
Journal
EJSO
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-31
DOI
10.1016/j.ejso.2021.07.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases
- (2021) Shin Kobayashi et al. ANNALS OF SURGICAL ONCOLOGY
- A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone for liver metastasis from colorectal cancer: JCOG0603 study.
- (2020) Yukihide Kanemitsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Laparoscopic procedure is associated with lower morbidity for simultaneous resection of colorectal cancer and liver metastases: an updated meta-analysis
- (2020) Long Pan et al. World Journal of Surgical Oncology
- Final results and OS of the randomized phase II VOLFI trial (AIO- KRK0109): mFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer (mCRC).
- (2019) Michael Geissler et al. JOURNAL OF CLINICAL ONCOLOGY
- Re-evaluating disease-free survival (DFS) as an endpoint versus overall survival (OS) in adjuvant colon cancer (CC) trials with chemotherapy +/- biologics: An updated surrogacy analysis based on 18,886 patients (pts) from the Accent database.
- (2019) Qian Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Efficacy of Preoperative, Postoperative, and Perioperative Treatments for Resectable Colorectal Liver Metastases: A Network Meta-Analysis
- (2019) Chao Huang et al. Frontiers in Pharmacology
- NCCN Guidelines Insights: Colon Cancer, Version 2.2018
- (2018) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer
- (2017) Gianluca Tomasello et al. JAMA Oncology
- Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis
- (2016) Giovanni Brandi WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases
- (2016) Emily Khoo et al. HPB
- Surgical Management of Liver Metastases From Colorectal Cancer
- (2016) Mashaal Dhir et al. Journal of Oncology Practice
- Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial
- (2016) Kiyoshi Hasegawa et al. PLoS One
- Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases
- (2015) Ashton A. Connor et al. ANNALS OF SURGICAL ONCOLOGY
- Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis
- (2015) Raphael L. C. Araujo et al. ANNALS OF SURGICAL ONCOLOGY
- Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial
- (2015) Ninos Ayez et al. BMC CANCER
- Peri-operative chemotherapy for patients with resectable colorectal hepatic metastasis: A meta-analysis
- (2015) Z.-M. Wang et al. EJSO
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
- (2015) Chiara Cremolini et al. LANCET ONCOLOGY
- Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
- (2014) T. Gruenberger et al. ANNALS OF ONCOLOGY
- Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
- (2014) John Primrose et al. LANCET ONCOLOGY
- Controversies in the oncosurgical management of liver limited stage IV colorectal cancer
- (2014) R.P. Jones et al. SURGICAL ONCOLOGY-OXFORD
- A Randomized Phase II Trial of Three Intensified Chemotherapy Regimens in First-Line Treatment of Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases. The METHEP Trial
- (2013) Marc Ychou et al. ANNALS OF SURGICAL ONCOLOGY
- Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
- (2013) Bernard Nordlinger et al. LANCET ONCOLOGY
- Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
- (2013) Audrey Mauguen et al. LANCET ONCOLOGY
- Durable Complete Responses in Metastatic Colorectal Cancer Treated with Chemotherapy Alone
- (2011) Renata Ferrarotto et al. Clinical Colorectal Cancer
- A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
- (2010) Nikol Snoeren et al. BMC CANCER
- Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials
- (2010) Martina Wieser et al. BMC CANCER
- Surgical management and outcomes of colorectal cancer liver metastases
- (2010) E. J. A. Morris et al. BRITISH JOURNAL OF SURGERY
- A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer
- (2009) M. Ychou et al. ANNALS OF ONCOLOGY
- Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases
- (2009) Gianluca Masi et al. ANNALS OF SURGERY
- The Role of Preoperative Chemotherapy in Patients with Resectable Colorectal Liver Metastases
- (2009) Stéphane Benoist et al. ANNALS OF SURGICAL ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials
- (2008) Emmanuel Mitry et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now